The intracranial pressure monitoring devices market size was estimated to be US$ 1.65 billion in 2021.
The global intracranial pressure monitoring devices market is estimated to exhibit a CAGR of 7% between 2023 to 2032.
The growing incidences of neurovascular disorders and rising cases of trauma and brain injuries have increased the demand for minimally invasive treatments and also increased the government initiatives to improve healthcare infrastructure. Such initiatives have accelerated market growth.
The major players operating in the intra cranial pressure (ICP) monitoring devices market are Medtronic, Johnson & Johnson Private Limited, RAUMEDIC AG, Integra LifeSciences, Natus Medical Incorporated, Terumo Corporation, Sophysa, Spiegelberg GmbH & Co. KG, Compumedics Limited, Shurtleff, Inc., HeadSense Medical, NeuroDx Development, Third Eye Diagnostics, Vivonics Inc., Covidien plc, Linet and others.
North America is one of the major contributors to the global intracranial pressure monitoring devices market.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved